ACCS vs BIIB · rev $10.9M vs P/E 21, rev $9.89B
ACCESS Newswire Inc. (ACCS) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
ACCESS Newswire Inc. (ACCS) is a advertising agencies company listed on AMEX.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported ACCS revenue for 2026-06-30 was $10.9M. Net income was -$1.1M. ACCS currently screens at market cap $24.1M.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
ACCS currently screens at market cap $24.1M. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the ACCS and BIIB stock pages for the full models.
Not investment advice.